Literature DB >> 6484194

Stem cell sensitivity.

M L Rosenblum, M A Gerosa.   

Abstract

Mesh：

Substances：

Year:  1984        PMID： 6484194

Source DB:  PubMed          Journal:  Prog Exp Tumor Res        ISSN： 0079-6263


× No keyword cloud information.
  7 in total

1.  Binding specificity of two monoclonal antiglioma antibodies: immunocytochemical studies using a new tissue embedding technique.

Authors:  S Krajewski; G Schwendemann; M Weizsäcker; W Wechsler; N de Tribolet
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

2.  Flow cytometry analysis of neural differentiation markers expression in human glioblastomas may predict their response to chemotherapy.

Authors:  Vladimir Balik; Peter Mirossay; Peter Bohus; Igor Sulla; Ladislav Mirossay; Marek Sarissky
Journal:  Cell Mol Neurobiol       Date:  2009-03-14       Impact factor: 5.046

3.  Chemotherapy for malignant gliomas of the brain: a review of ten-years experience.

Authors:  P Paoletti; G Butti; R Knerich; P Gaetani; R Assietti
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

4.  Subcapsular renal transplantation of neurogenic tumors and tumor spheroids. A comparative study of RN6 and RG2 tumor clones after syngeneic and allogeneic transplantation.

Authors:  S Krajewski; K Rathmer; H Hamada; M Weizsäcker; B Eberhardt; W Wechsler
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

5.  Hyperthermic potentiation of BCNU toxicity in BCNU-resistant human glioma cells.

Authors:  V F Da Silva; M Feeley; G P Raaphorst
Journal:  J Neurooncol       Date:  1991-08       Impact factor: 4.130

Review 6.  In vitro chemosensitivity testing and its clinical application in human gliomas.

Authors:  W K Yung
Journal:  Neurosurg Rev       Date:  1989       Impact factor: 3.042

7.  Glutathione levels and chemosensitizing effects of buthionine sulfoximine in human malignant glioma cells.

Authors:  M J Allalunis-Turner; R S Day; J D McKean; K C Petruk; P B Allen; K E Aronyk; B K Weir; D Huyser-Wierenga; D S Fulton; R C Urtasun
Journal:  J Neurooncol       Date:  1991-10       Impact factor: 4.130
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.